Clinical Trial Update: Effect of Probiotic Use Bifidobacterium Animalis Subsp. Lactis in Peri-implant Mucositis [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the effect of Bifidobacterium animalis subsp. lactis probiotic use on peri-implant mucositis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucositis Oral

Drugs mentioned

• Bifidobacterium animalis subsp. lactis (Bifidobacterium animalis subsp. lactis)

Snippet

Sponsor: University of Sao Paulo | Conditions: Mucositis Oral | Phase 3 | Status: COMPLETED